Discontinuation of quarantine of the patient infected with SARS-CoV-2 over 100 days.

QJM

From the Department of Nephrology, Tsukuba Gakuen Hospital, 2573-1 Kamiyokoba, Tsukuba, Ibaraki 305-0854, Japan.

Published: August 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083577PMC
http://dx.doi.org/10.1093/qjmed/hcab049DOI Listing

Publication Analysis

Top Keywords

discontinuation quarantine
4
quarantine patient
4
patient infected
4
infected sars-cov-2
4
sars-cov-2 100
4
100 days
4
discontinuation
1
patient
1
infected
1
sars-cov-2
1

Similar Publications

During the COVID-19 pandemic, people were asked to stay at home. Places where people interacted such as schools, universities, and cafes were closed, and all gatherings were forbidden. Only stores offering fast-moving consumer goods were open, so citizens could purchase all food categories.

View Article and Find Full Text PDF

Objective: The aim of the present study is to investigate the change in emotional/behavioral problems of children with autism spectrum disorder (ASD) and the perceived social support of parents during the coronavirus disease 2019 (COVID-19) pandemic.

Methods: A total of 51 children with ASD aged between 6 and 18 years took part in the study. The Aberrant Behavior Checklist (ABC), the Strengths and Difficulties Questionnaire (SDQ), and the Multidimensional Scale of Perceived Social Support (MSPSS) were used to evaluate ASD symptoms, emotional/behavioral problems, and perceived social support, respectively.

View Article and Find Full Text PDF

Purpose: We aimed to evaluate the influence of easing COVID-19 preventive measures following its downgrading to a common infectious disease on COVID-19 occurrence among hospitalized patients.

Methods: Nosocomial occurrence of COVID-19 was compared between periods with national infectious disease category 5 versus the preceding category 2 equivalent. Changes in the revised manual included a shorter duration of work restrictions for infected health care practitioners (HCPs); no work restriction for HCPs exposed to SARS-CoV-2 with a negative test on days 1, 3 and 5; discontinuation of universal pre-admission screening; and pre-emptive isolation of patients without screening.

View Article and Find Full Text PDF
Article Synopsis
  • - Nirmatrelvir/ritonavir is an important COVID-19 treatment for outpatient settings, but it can lead to dangerous interactions with tacrolimus in transplant patients, potentially causing toxicity.
  • - In a case series of 5 transplant recipients, they experienced high tacrolimus levels and toxicity after taking nirmatrelvir/ritonavir, leading to the temporary discontinuation of both drugs.
  • - The introduction of phenytoin helped lower tacrolimus levels effectively, suggesting it could be a viable strategy for managing this issue in similar patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!